Latest evidence-based view
BULZ · HOLD
BULZ (MicroSectors Solactive FANG & Innovation 3X…) multiplies daily moves, making the compounding path more important than a long-range forecast. One-month (+11.46%) and three-month (-30.42%) evidence is not decisive enough for a directional call.
BULZ currently supports a wait stance.
One-month (+11.46%) and three-month (-30.42%) evidence is not decisive enough for a directional call.
The opposing case is clear: Choppy markets can erode value even when the broad direction is right. The 0.95% annual expense ratio is deducted throughout ownership. The stance remains tied to the observed price trend.
Use staged sizing and reassess when the one- and three-month trends no longer support this stance.